Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ran Yan

Showing results (301-310 of 309) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 309 results.
Blood Cancer Discovery|September 14, 2020
Combinatorial ETS1-dependent control of oncogenic NOTCH1 enhancers in T-cell leukemiaAnna C McCarter, Giusy Della Gatta, Ashley Melnick, et al.
International Journal of Hygiene and Environmental Health|September 8, 2020
Impacts of transportation and meteorological factors on the transmission of COVID-19Jia-Te Wei, Yun-Xia Liu, Yu-Chen Zhu, et al.
Bjpsych Open|June 29, 2021
Protocol for a pharmacogenomic study on individualised antipsychotic drug treatment for patients with schizophreniaYi Su, Hao Yu, Zhiren Wang, et al.
Cell|June 25, 2025
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosisXiaobing Wang, Yi Zhang, Yi Jin, et al.
JHEP Reports : Innovation in Hepatology|March 21, 2024
Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responsesMan-Fung Yuen, Scott Fung, Xiaoli Ma, et al.
Radiology. Imaging Cancer|January 5, 2024
Breast Multiparametric MRI for Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer: The BMMR2 ChallengeWen Li, Savannah C Partridge, David C Newitt, et al.
Journal of Hepatology|June 13, 2022
Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infectionMark S Sulkowski, Kosh Agarwal, Xiaoli Ma, et al.
Journal of Hepatology|April 23, 2022
Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infectionMan-Fung Yuen, Kosh Agarwal, Xiaoli Ma, et al.
Nature Medicine|August 27, 2025
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trialXiaobing Wang, Yi Zhang, Huimin Wang, et al.
Pageof 31

Showing results (301-310 of 309) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 309 results.
Blood Cancer Discovery|September 14, 2020
Combinatorial ETS1-dependent control of oncogenic NOTCH1 enhancers in T-cell leukemiaAnna C McCarter, Giusy Della Gatta, Ashley Melnick, et al.
International Journal of Hygiene and Environmental Health|September 8, 2020
Impacts of transportation and meteorological factors on the transmission of COVID-19Jia-Te Wei, Yun-Xia Liu, Yu-Chen Zhu, et al.
Bjpsych Open|June 29, 2021
Protocol for a pharmacogenomic study on individualised antipsychotic drug treatment for patients with schizophreniaYi Su, Hao Yu, Zhiren Wang, et al.
Cell|June 25, 2025
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosisXiaobing Wang, Yi Zhang, Yi Jin, et al.
JHEP Reports : Innovation in Hepatology|March 21, 2024
Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responsesMan-Fung Yuen, Scott Fung, Xiaoli Ma, et al.
Radiology. Imaging Cancer|January 5, 2024
Breast Multiparametric MRI for Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer: The BMMR2 ChallengeWen Li, Savannah C Partridge, David C Newitt, et al.
Journal of Hepatology|June 13, 2022
Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infectionMark S Sulkowski, Kosh Agarwal, Xiaoli Ma, et al.
Journal of Hepatology|April 23, 2022
Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infectionMan-Fung Yuen, Kosh Agarwal, Xiaoli Ma, et al.
Nature Medicine|August 27, 2025
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trialXiaobing Wang, Yi Zhang, Huimin Wang, et al.
Pageof 31